Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck & Co. presents DGAT-2 inhibitors

April 29, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Chinese investigators patent new THR-beta agonists

April 25, 2022

Ono establishes collaborations to discover small molecules targeting GPCRs in metabolic disease

April 20, 2022

Microbe-sensing mechanism via neuronal Nod2 regulates appetite and metabolism

April 19, 2022

Artelo reports new preclinical data for GPCR agonist ART-27.13 for cancer-induced cachexia

April 14, 2022

FGFR2-selective inhibitor CGT-0292 shows promise for treating hyperphosphatemia

April 13, 2022

UCL Business synthesizes new TTR stabilizers

April 11, 2022

Cadila Healthcare discloses new ACP1 inhibitors

April 8, 2022

PX-478 prevents rise of glycemia and improves beta-cell function in models diabetes

April 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...